PHILADELPHIA – The world's largest maker of generic pharmaceutical products alleges that a former employee misappropriated trade secrets.
Teva Pharmaceuticals USA Inc. filed a complaint on July 7 in the U.S. District Court for the Eastern District of Pennsylvania against Barinder Sandhu, Jeremy Desai, Apotex Inc. and Apotex Corp. alleging violation of the Trade Secrets Act, the Computer Fraud and Abuse Act and other counts.
According to the complaint, the plaintiff alleges that Sandhu was a senior director of regulatory affairs with it and was in a relationship with Desai, a senior executive with defendants Apotex. It alleges Sandhu shared trade secrets with Desai.
The plaintiff holds Sandhu, Desai, Apotex Inc., and Apotex Corp. responsible because Apotex allegedly gained a competitive advantage over the plaintiff with the use of the unlawfully shared information.
The plaintiff requests a trial by jury and seeks order the return of plaintiff's trade secrets and other confidential information, actual and exemplary damages, compensatory damages, punitive damages, injunctive relief, court costs and any further relief this court grants. It is represented by Christopher J. Belter, John F. Parker and Paul S. Danner of Goldberg Segalla LLP in New York.
U.S. District Court for the Eastern District of Pennsylvania case number 2:17-cv-03031-TON